低分子质量肝素的临床应用

[1] Angiogenic effects ofLM WHin patients with stable coronary disease :a pilot study. Quyyumi AA,Diodati JG,Lakatos E,et al. Journal of the American College of Cardiology . 1993

[2] Effect of heparinand heparin fractionson platelet aggregation. Salzman EW,Rosenberg RD,Smith MH,et al. The Journal of Clinical Investigation . 1980

[3] 肝素与低分子量肝素治疗不稳定性心绞痛的比较 [J]. 中国新药与临床杂志, 1998, (04) : 6 - 8

[4] 低分子量肝素对大鼠内毒素休克的保护作用 [J]. 中国危重病急救医学, 1996, (03) : 6 - 9+64

[5] 单剂量低分子量肝素在血液透析抗凝中的应用 [J]. 中华肾脏病杂志, 1996, (01) : 32 - 35

[6] Low molecular weight heparin forthe treatment of acute ischemic stroke. Kay R,Wong KS,YU YL,et al. The New England Journal of Medicine . 1995

[7] Low molecular weighheparin(Enoxaparin) reduces restenosis after iliac angioplasty in thehyperchloesterolemic rabbit. Curier JW,Po TK,Haudeschild CC,et al. Journal of the American College of Cardiology . 1991

[1] Angiogenic effects ofLM WHin patients with stable coronary disease :a pilot study. Quyyumi AA,Diodati JG,Lakatos E,et al. Journal of the American College of Cardiology . 1993

[2] Effect of heparinand heparin fractionson platelet aggregation. Salzman EW,Rosenberg RD,Smith MH,et al. The Journal of Clinical Investigation . 1980

[3] 肝素与低分子量肝素治疗不稳定性心绞痛的比较 [J]. 中国新药与临床杂志, 1998, (04) : 6 - 8

[4] 低分子量肝素对大鼠内毒素休克的保护作用 [J]. 中国危重病急救医学, 1996, (03) : 6 - 9+64

[5] 单剂量低分子量肝素在血液透析抗凝中的应用 [J]. 中华肾脏病杂志, 1996, (01) : 32 - 35

[6] Low molecular weight heparin forthe treatment of acute ischemic stroke. Kay R,Wong KS,YU YL,et al. The New England Journal of Medicine . 1995

[7] Low molecular weighheparin(Enoxaparin) reduces restenosis after iliac angioplasty in thehyperchloesterolemic rabbit. Curier JW,Po TK,Haudeschild CC,et al. Journal of the American College of Cardiology . 1991